埃莫丁是一种潜在的药物,向CD44阳性肝细胞癌
Yuan Gao1, Youling Li2, Yunhe Zhu2
1Department of General Medicine, Renmin Hospital, Hubei University of Medicine, Shiyan City, Hubei Province, 442000, P.R. China.
Current cancer drug targets
|December 15, 2023
概括
埃莫丁有效抑制肝细胞癌 (HCC) 细胞生长和转移. 这种天然化合物在肝癌治疗中有望向癌症干细胞 (CSC).
科学领域:
- 在瘤学瘤学.
- 肝病学 肝病学是一种肝病学.
- 癌症干细胞研究研究
背景情况:
- 肝细胞癌 (HCC) 是一种常见的消化系统癌症,治疗结果不佳.
- 目前的HCC疗法面临的挑战包括药物耐药性,转移和复发.
- 癌症干细胞 (CSC) 参与HCC的发展和复发.
研究的目的:
- 调查埃莫丁作为HCC治疗剂的潜力.
- 分析埃莫丁对HCC细胞生长,转移和干细胞的作用.
主要方法:
- 利用HepG2和Huh7细胞系进行抗瘤活性分析.
- 量化细胞生长和转移作为对emodin的反应.
- 评估了埃莫丁对癌症干细胞特性的影响.
主要成果:
- 埃莫丁显著抑制了HCC细胞的生长和迁移.
- 埃莫丁在CD44阳性肝瘤细胞中显著抑制了增殖.
结论:
- 埃莫丁具有作为HCC治疗剂的潜力.
- 用埃莫丁向CD44阳性肝瘤细胞可能是治疗HCC的有效策略.
关键词:
CD44.44. CD44.44. CD44.44. CD44.44. CD44.44. CD44.44. CD44.44. CD44.44. CD44.5 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4 CD44.4埃莫迪因 (Emodin) 是一种催产素.癌症干细胞是癌症干细胞.肝细胞癌是肝细胞癌.肝癌 肝癌 是一种肝癌.树干性 树干性相关概念视频
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


